Triple-Negative Breast Cancer: Samantha's Survivor Story

Patient Info: Samantha Salway, Female, Under 40

Biomarkers: ER-negative; PR-negative; HER2-negative

As of May 2024, Samantha had delivered a healthy baby, completed chemotherapy, lumpectomy, radiation and additional chemotherapy, had no current evidence of cancer, and remained under close monitoring.

Cleveland ClinicRead more →

Triple-negative breast cancer and ovarian cancer treated with chemotherapy and PARP inhibitor

Patient Info: Anonymized, Female, 40s | Stage III

Biomarkers: Germline pathogenic BRCA2 c.6468_6469del; breast tumor triple-negative

As of April 2024, 6-week follow-up after breast and nodal radiation was unremarkable, erythema had resolved, and no breast, chest wall, respiratory, or axillary abnormality was found; longer-term control was not reported.

PubMed CentralRead more →

Vision problems led to a breast cancer diagnosis (cancer-associated retinopathy)

Patient Info: Anonymized, Female

Biomarkers: Anti-recoverin and anti-alpha-enolase antibodies associated with cancer-associated retinopathy; tumor biomarkers not reported

Six years after her initial visual symptoms, vision remained stable and she remained cancer-free on surveillance.

PubMed CentralRead more →

Malignant Phyllodes Tumor Recurs Early Along the Biopsy Tract in a Young Woman

Patient Info: Anonymized, female

Biomarkers: No pathogenic germline mutations identified; MLH1 variant of uncertain significance

Clinical examination, breast MRI, and chest CT showed no evidence of disease at about 3 months after the recurrence surgery and before the 6-month follow-up.

PubMed CentralRead more →

High-Grade Mucoepidermoid Carcinoma of the Breast Treated With Surgery

Patient Info: Anonymized, female, 40s

Biomarkers: ER low-positive; PR-negative; HER2-negative; AR-positive; no MAML2 rearrangement

At 1-year follow-up, there was no local recurrence or distant metastasis.

PubMed CentralRead more →

Stage III Breast Cancer: Gail's Patient Story

Patient Info: Gail, Female, 60s | Stage III

Biomarkers: Luminal A

As of 2024, Gail had Stage III luminal A breast cancer and was awaiting the start of planned treatment with lumpectomy, radiation therapy, chemotherapy, and hormone therapy.

Our Cancer StoriesRead more →

Hormone-Receptor-Positive Breast Cancer Treated in 1996 Before a Later Separate Primary

Patient Info: Anonymized, female

Biomarkers: Hormone receptor-positive

The later tumor in the same breast was assessed as a separate primary rather than a late recurrence of the 1996 cancer.

PubMed CentralRead more →

Five Years Without Breast Cancer Recurrence Despite a Markedly Elevated CA 15-3

Patient Info: Anonymized, female, 70+ | Stage I

Biomarkers: ER-positive, PR-positive, HER2-positive

Five years after her Stage I breast-cancer diagnosis, breast imaging and systemic evaluation showed no evidence of recurrence. The markedly elevated CA 15-3 was traced to a separate renal tumor and normalized after nephrectomy.

PubMed CentralRead more →

Breast cancer lung metastasis treated with a minimally invasive freezing procedure

Patient Info: Anonymized, Female | Stage IV

Biomarkers: HER2-positive; ER-negative

Metastatic Site: lungs

Follow-up PET/CT at 3, 6, 9 and 12 months after cryoablation showed no progression or new lesions without systemic therapy.

PubMed CentralRead more →

Triple-Negative Breast Cancer: Susan's Patient Story

Patient Info: Susan, Female, 70+

Biomarkers: BRCA negative; earlier breast cancer described as triple-negative; later breast cancer estrogen-positive and progesterone-positive; HER2 not reported

As of August 2023, Susan was living after multiple breast cancer diagnoses, including a later estrogen-positive/progesterone-positive non-metastatic breast cancer treated with bilateral mastectomy and ongoing 5-year estrogen-blocker therapy.

The Patient StoryRead more →

HER2-Positive Breast Cancer: Susan's Survivor Story

Patient Info: Susan, Female, 70+

Biomarkers: 2021 breast cancer described as estrogen-positive and progesterone-positive; HER2 not reported. First breast cancer biomarker status not reported.

As of August 2023, Susan was living in survivorship after a first breast cancer treated with lumpectomy, chemotherapy, and radiation and a later separate breast cancer treated with bilateral mastectomy.

The Patient StoryRead more →

Stage II HR-Positive Invasive Lobular Carcinoma: Megan's Survivor Story

Patient Info: Megan Claire Chase, Female | Stage II

Biomarkers: ER-positive; PR-positive; HER2 not reported

As of July 2023, Megan-Claire was in survivorship after Stage II invasive lobular breast cancer, with clear early scans but significant long-term effects, surgical menopause, chronic pain, fatigue, chemo brain, and inability to tolerate recurrence-prevention medications.

The Patient StoryRead more →

Stage II Invasive Lobular Carcinoma: Megan-Claire's Survivor Story

Patient Info: Megan-Claire, Female, Under 40 | Stage II

As of July 2023, Megan-Claire had completed chemotherapy, breast-conserving surgery with reconstruction/reduction, and 33 radiation rounds, and was living with long-term effects including neuropathy, scarring, fatigue, and radiation trauma; no recurrence or NED status was stated.

The Patient StoryRead more →

Invasive Lobular Carcinoma: Lucinda's Patient Story

Patient Info: Lucinda Rudolph, Female, 60s

As of June 2023, Lucinda was living well after treatment for locally advanced recurrent invasive lobular breast cancer, taking exemestane, receiving supportive care for neuropathy, and returning to MD Anderson every 6 months for checkups.

MD AndersonRead more →

Stage III HR-Positive Breast Cancer: Sarah's Survivor Story

Patient Info: Sarah McDonald, Female, 40s | Stage III

Biomarkers: ER-positive; PR-positive; HER2-negative

Sarah was 10 years from diagnosis without a recurrence and described the breast cancer as successfully treated. She later paused hormone therapy, completed IVF and gave birth at age 48.

The Patient StoryRead more →

Stage III HER2-Positive Breast Cancer: Christine's Survivor Story

Patient Info: Christine Elliott, Female, Under 40 | Stage III

Biomarkers: Estrogen receptor-positive; HER2 and progesterone receptor status not reported

As of May 2023, Christine was about 3 years from diagnosis and in survivorship after chemotherapy, lumpectomy, and radiation. She reported lasting physical and emotional effects but did not state a formal NED status.

YouTube — The Patient StoryRead more →

Rare breast cancer subtype that recurred years later in a more aggressive form

Patient Info: Anonymized, Female | Stage IV

Biomarkers: CD117 focally positive in the transformed component; high Ki-67; hormone-receptor status was unknown at the original diagnosis

Metastatic Site: lungs

One year after treatment for the late chest-wall recurrence, CT showed another local recurrence and metastatic nodules in both lungs. She chose to continue treatment elsewhere.

PubMed CentralRead more →

Stage I Invasive Lobular Carcinoma: Carol's Survivor Story

Patient Info: Carol, Female, 70+ | Stage I

Carol recovered from lumpectomy for stage 1A disease and was doing well on an aromatase inhibitor, with occasional hot flashes.

Lobular Breast Cancer AllianceRead more →

Breast Cancer: Maeve's Patient Story

Patient Info: Maeve

Maeve had undergone lumpectomy, lymph-node surgery, chemotherapy, radiation, and targeted therapy and was focused on returning to work and being present for her family.

Our Cancer StoriesRead more →

Stage II Breast Cancer: Char's Patient Story

Patient Info: Char, Female, 40s | Stage II

As of 2023, Char was focused on surviving Stage II breast cancer after lumpectomy, lymphadenectomy, chemotherapy, and radiotherapy, while rebuilding diet, exercise, work, family life, and mental health.

Our Cancer StoriesRead more →

Stage I Breast Cancer: Gayna's Survivor Story

Patient Info: Gayna, Female, 50s | Stage I

Gayna completed treatment for Stage I breast cancer and described optimism, thankfulness, permanent diet/exercise changes, and plans to stay well and enjoy life.

Our Cancer StoriesRead more →

Stage II Breast Cancer: Grace's Patient Story

Patient Info: Grace, Female, 60s | Stage II

Grace was still in treatment for Stage II breast cancer, including lumpectomy-based care, chemotherapy, radiation therapy, and immunotherapy, and reported that treatment was working despite difficult side effects and job loss.

Our Cancer StoriesRead more →

Stage I Breast Cancer: Hu's Patient Story

Patient Info: Hu Jia, Female | Stage I

As of 2023, Hu Jia was in treatment for Stage I breast cancer after choosing a modified plan that excluded lymphadenectomy, while anticipating future medication costs and focusing on diet, art, reflection, and emotional resilience.

Our Cancer StoriesRead more →

Breast Cancer: Grace's Patient Story

Patient Info: Grace

Grace remained on medication after lumpectomy, lymph-node surgery, radiation therapy, and hormone therapy for breast cancer diagnosed through routine testing.

Our Cancer StoriesRead more →